Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 10
Submit an article Journal homepage
570
Views
16
CrossRef citations to date
0
Altmetric
Letter

Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

Francesca PastorelliInstitute of Neurological Sciences of Bologna, “Bellaria” Hospital, Bologna, Italy
,
Enrico DerenziniInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
,
Rosaria PlasmatiInstitute of Neurological Sciences of Bologna, “Bellaria” Hospital, Bologna, Italy
,
Cinzia PellegriniInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
,
Alessandro BroccoliInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
,
Beatrice CasadeiInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
,
Lisa ArgnaniInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
,
Fabrizio SalviInstitute of Neurological Sciences of Bologna, “Bellaria” Hospital, Bologna, Italy
,
Stefano PileriInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, Italy
&
Pier Luigi ZinzaniInstitute of Hematology “L e A Seràgnoli”, University of Bologna, Bologna, ItalyCorrespondence[email protected]
 show all
Pages 2318-2321 | Received 05 Dec 2012, Accepted 03 Feb 2013, Published online: 08 Mar 2013

References

  • Gualberto A. Brentuximab vedotin (SGN-35), an antibody-drug conjugate for the treatment of CD30-positive malignancies. Expert Opin Investig Drugs 2012;21:205–216.
  • Younes A, Gopal AK, Smith SE, et al. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol 2012;30:2183–2189.
  • Plasmati R, Pastorelli F, Cavo M, et al. Neuropathy in multiple myeloma treated with thalidomide: a prospective study. Neurology 2007;69:573–581.
  • Younes A, Bartlett NL, Leonard JP, et al. Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. N Engl J Med 2010;363:1812–1821.
  • Fanale MA, Forero-Torres A, Rosenblatt JD, et al. A phase I weekly dosing study of brentuximab vedotin in patients with relapsed/refractory CD30-positive hematologic malignancies. Clin Cancer Res 2012;18:248–255.
  • Gopal AK, Ramchandren R, O’Connor OA, et al. Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplant. Blood 2012;120:560–568.
  • De Angelis LM, Posner JB, editors. Neurologic complications of cancer. 2nd ed. New York: Oxford University Press; 2009. pp 447–510.
  • Gwathmey K, Balogun RA, Burns T. Neurologic indications for therapeutic plasma exchange: 2011 update. J Clin Apher 2012;27: 138–145.
  • Khatri BO, Man S, Giovannoni G, et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 2009;72:402–409.
  • Carpo M, Cappellari A, Mora G, et al. Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998;50:1480–1482.
  • Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 2006;24:1633–1642.
  • Swain SM, Arezzo JC. Neuropathy associated with microtubule inhibitors:diagnosis, incidence, and management. Clin Adv Hematol Oncol 2008;6:455–467.
  • Schwarting R, Gerdes J, Durkop H, et al. BER-H2: a new anti-ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 1989;74:1678–1689.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.